<DOC>
	<DOCNO>NCT02986074</DOCNO>
	<brief_summary>The study compare therapeutic efficacy novel spinal cord stimulation lead implant base anatomical landmark standard surgical implantation technique .</brief_summary>
	<brief_title>CompaRison Paresthesia Mapping anatomIc Midline-based burSt Programming Strategies</brief_title>
	<detailed_description>The primary purpose study compare therapeutic efficacy conventional , paresthesia mapping-based burst spinal cord stimulation ( SCS ) implantation strategy novel , anatomic midline-based approach potential streamline workflow associate SCS treatment continuum .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Paresthesia</mesh_term>
	<criteria>Subject able provide inform consent participate study ; Subject 18 year age old ; Subject fail respond least 6 month conventional treatment include pharmacological treatment , physical therapy , epidural injection and/or radiofrequency therapy per NICE Tag 0159 ; FBSS subject predominant low back pain ; Subject low back pain intensity least 6.0 10.0 VAS baseline ; Subject stable pain medication total opioid equivalent 120 mgs day less least 28 day prior enrol study , willing stay medication dose adjustment activation permanently implant SCS device ; Subject 's medical record evaluate Investigator ensure subject good candidate neurostimulation system ; Subject willing cooperate study requirement include compliance regimen completion office visit ; Female candidate childbearing potential agree commit use effective method contraception ( include limit sterilization , barrier device , oral contraceptive , intrauterine device ( IUDs ) , condom , rhythm method , abstinence ) duration study Subjects significant scoliosis even surgically correct Subject currently participate clinical investigation include active treatment arm ; Subject implant participated trial period neurostimulation system ; Subject infusion pump ; Subject evidence active disruptive psychological psychiatric disorder determine per standard care ; Subject current diagnosis coagulation disorder , bleed diathesis , progressive peripheral vascular disease uncontrolled diabetes mellitus ; Subject current diagnosis progressive neurological disease determine Investigator ; Subject immunocompromised ; Subject exist medical condition likely require repetitive MRI evaluation future ( i.e . epilepsy , stroke , multiple sclerosis , acoustic neuroma , tumor ) ; Subject history cancer require active treatment last 12 month ; Subject exist medical condition likely require use diathermy future ; Subject document history allergic response titanium silicone ; Subject document history substance abuse ( narcotic , alcohol , etc . ) substance dependency 6 month prior baseline data collection ; Female candidate child bear potential pregnant ( confirm positive urine/blood pregnancy test ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>